SCHEMBL4717339

SCHEMBL4717339

CCOC(=O)C(N)Cc1ccc(Br)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
RAB9A P51151 3/20 0.42
KMT2A Q03164 2/20 0.42
PKM P14618 2/20 0.42
TPH1 P17752 2/20 0.41
SLC7A5 Q01650 2/20 0.39
KDM4E B2RXH2 1/20 0.39
USP2 O75604 1/20 0.39
EGFR P00533 1/20 0.39
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
ALOX15 P16050 1/20 0.39
PTGS1 P23219 1/20 0.39
HTR2A P28223 1/20 0.39
PTGS2 P35354 1/20 0.39
RECQL P46063 1/20 0.39
HIF1A Q16665 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3316938 0.99 TPH1 (0.42) ALDH1A1RAB9AKMT2APKMTPH1
SCHEMBL4035263 0.90 TPH1 (0.42) ALDH1A1KMT2APKMTPH1SLC7A5
SCHEMBL4035478 0.90 TPH1 (0.42) ALDH1A1KMT2APKMTPH1SLC7A5
SCHEMBL3877275 0.90 TPH1 (0.42) ALDH1A1KMT2APKMTPH1SLC7A5
SCHEMBL3278235 0.86 ALDH1A1 (0.42) ALDH1A1PKMTPH1SLC7A5KDM4E
SCHEMBL18554069 0.83 SLC7A5 (0.57) KMT2APKMSLC7A5KDM4EUSP2
SCHEMBL3751437 0.83 KDM4E (0.49) ALDH1A1TPH1SLC7A5KDM4EUSP2
SCHEMBL4717979 0.82 SMN1; SMN2 (0.43) ALDH1A1RAB9AKMT2APKMTPH1
SCHEMBL7960935 0.82 SLC7A5 (0.48) ALDH1A1PKMTPH1SLC7A5PTGS1
Hydrochloric Acid SCHEMBL20474572 0.82 SLC7A5 (0.55) KMT2APKMSLC7A5KDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558600-B1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2008-05-07 EP disclosed
EP-1558600-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-08-03 EP disclosed
WO-2004037810-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-05-06 WO disclosed